Catherine Patte

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Catherine Patte, Anne Aupérin, Mary Gerrard et al. · Blood · 2006 · 432 citations · Full text

Medicine, Oncology, Pediatrics +9

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease

Gabriele Calaminus, Rolf‐Dieter Kortmann, Jennifer Worch et al. · Neuro-Oncology · 2013 · 373 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

Mitchell S. Cairo, Mary Gerrard, Richard Sposto et al. · Blood · 2006 · 363 citations · Full text

Medicine, Oncology, Pediatrics +13

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Véronique Minard‐Colin, Anne Aupérin, Marta Pillon et al. · New England Journal of Medicine · 2020 · 312 citations · Full text

Medicine, Oncology, Pediatrics +15

High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.

Catherine Patte, Thierry Philip, C Rodary et al. · Journal of Clinical Oncology · 1991 · 296 citations

Medicine, Oncology, Pediatrics +16